To evaluate the clinical relevance of KCTD17, we compared RNA sequencing (RNA-seq) in healthy (GSE130970) or biopsy-proven non-MASH controls (GSE167523) with that from patients with MASH. The gene discussed is KCTD17; the disease is metabolic dysfunction-associated steatohepatitis.